Jupiter Neurosciences Inc./$JUNS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jupiter Neurosciences Inc.
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
Ticker
$JUNS
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
4
Website
JUNS Metrics
BasicAdvanced
$46M
-
-$0.11
-
-
Price and volume
Market cap
$46M
52-week high
$3.33
52-week low
$0.51
Average daily volume
570K
Financial strength
Current ratio
1.911
Quick ratio
1.432
Long term debt to equity
0.278
Total debt to equity
6.705
Interest coverage (TTM)
-22.08%
Profitability
Management effectiveness
Return on assets (TTM)
-99.87%
Return on equity (TTM)
225.64%
Valuation
Price to book
15.12
Price to tangible book (TTM)
15.12
Price to free cash flow (TTM)
-8.678
Free cash flow yield (TTM)
-11.52%
Free cash flow per share (TTM)
-0.161
Growth
Earnings per share change (TTM)
-21.05%
3-year earnings per share growth (CAGR)
-17.86%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Jupiter Neurosciences Inc. stock?
Jupiter Neurosciences Inc. (JUNS) has a market cap of $46M as of August 01, 2025.
What is the P/E ratio for Jupiter Neurosciences Inc. stock?
The price to earnings (P/E) ratio for Jupiter Neurosciences Inc. (JUNS) stock is 0 as of August 01, 2025.
Does Jupiter Neurosciences Inc. stock pay dividends?
No, Jupiter Neurosciences Inc. (JUNS) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Jupiter Neurosciences Inc. dividend payment date?
Jupiter Neurosciences Inc. (JUNS) stock does not pay dividends to its shareholders.
What is the beta indicator for Jupiter Neurosciences Inc.?
Jupiter Neurosciences Inc. (JUNS) does not currently have a Beta indicator.